Legal information

GDPR Position Statement

London, UK – 15 October 2018: A new European Union personal data (PD) protection regulation – GDPR (General Data Protection Regulation) came into force on 25 May 2018. Ergomed plc together with its affiliated companies (jointly: Ergomed plc Group Entities or EGE, as listed below) has always been committed to high standards of data security. In this spirit, we are now revising our policies and procedures to meet the requirements of GDPR as further elaborated.

EGE identified 16 purposes of PD processing, assigned the legal basis to each purpose as per GDPR, specified appropriate categories of data subjects and categories of PD and set up the Data Protection Impact Analysis (DPIA), which constitute the core for PD processing as per GDPR.

For most of the PD processing purposes we are the data processor, as our clients are the controller, because we process PD on behalf of the controller in order to perform under the relevant contract. The controller determines the purposes and means of PD processing regarding the regulatory obligations and controller’s business needs. The controller may pass some of its obligations on its processor and such obligations have to be specified in the contract between the controller and the processor.

We involve service providers for some business services, which are our processors (processors of deeper level or sub-processors). It is our responsibility to determine the means of PD processing in a contract with each our vendor (sub-processor). We will take care to impose the same data protection obligations on our sub-processors as set out between us and the controller, in contracts with our sub-processors.

We are the controller for some of our PD processing purposes such as for employee’s PD processing, independent contractor’s PD processing and client’s / vendor’s PD processing.

Ergomed plc appointed its Data Protection Officer (DPO) for all EGE who may be contacted at DPO will coordinate his activity in specific PD processing (clinical trials, pharmacovigilance service, etc.) with EGE’s clients’ and vendors’ data protection officers. Ergomed plc decided that the Information Commissioner’s Office, UK will act as the Lead Supervisory Authority for Supervisory Authority related obligations.

We are in the process of updating the contracts with our controllers as well as with our sub-processors  (sites, investigators, etc.) to include GDPR obligations / provisions.

We also updated our forms, templates and procedural documents used in our services to be GDPR compliant (investigator–related and reporter–related as well as the patient–related). We implement a correct PD processing also in cases when the controllers and/or recipients of personal data e.g. our EGE, clients and vendors are located outside the EEA in countries which do not ensure an adequate level of the PD protection by GDPR Article 45.

The current business processes will not be changed. We will raise the protection and security of the PD in the processing to GDPR requirements including the identification of data subjects and their PD processed. We combine regulatory laws obligations regarding PD protection with new GDPR obligations in PD processing – pseudonymization and others. We are ready to respond to data subject’s requests to exercise their rights. Our procedural documents specify the processes for data breach notification.

We also train our staff in terms of both personal data protection policies and security risks.

Our current activities focus on maintaining the GDPR compliance in line with the established requirements. Our security measures regarding PD processing have always been on high level but we continue working on additional improvements of PD processing methods. We concentrate on precision in fulfilling GDPR obligations as well as on the PD processing security improvements using up-to-date cyber security and physical security technology.

We understand that meeting the GDPR requirements will take a lot of time and effort and as your partner we want to assure you of our commitment to continuous compliance including GDPR.

Please do not hesitate to contact our DPO with any questions that you may have.

Click here to visit Ergomed plc website for more information.

PrimeVigilance Ltd, an Ergomed plc Group Company.

1 Occam Court
Surrey Research Park
Guildford, Surrey
United Kingdom
Phone: +44 (0)1483 307920

Terms of use
Ergomed Plc, with seat at 1 Occam Court, Surrey Research Park, Guildford, Surrey, GU2 7HJ, United Kingdom, as the parent company together with its worldwide affiliated companies, including among others PrimeVigilance Limited,  belongs to the same group companies (further: “ERGOMED Group”). By accessing this Internet world wide web site (further: “the Site) the users signify their assent to these Terms of use. Ergomed Group reserves the right to change these Terms of use at any time in its sole discretion. Ergomed Group will post those changes on the Site. When using Site features, the user may be subject to any additional posted guidelines or policies which are incorporated by reference into these Terms of use.

Ownership of Site, Copyright © and Trademarks
The Site and all its contents including, but not limited to all text, images, graphics, sound files, animation files, video files, button icons, software and their arrangement (further: “Content”) are exclusively owned and protected by copyright of ERGOMED Group and international copyright laws. The Site also contains images that are subject to the copyright rights of their owners.

Content may be used solely for non-commercial and personal information purposes. Any other use of Content including copying, modification, distribution, transmission, republication, display, performance and reposting to other sites without previous written approval of ERGOMED Group is strictly prohibited. The Site shall not be used for any unlawful purpose or in violation of applicable law or regulation. The users are prohibited from reverse engineering, decompiling, disassembling, or attempting to derive source code from any part of the Site.

All trademarks, logos and service marks on the Site are proprietary trademarks, logos or services marks of Ergomed Group and its business partners and the user may not use any of them without the written permission of the owner.

Any violation of Content’s copyright or other intellectual property right is subject to legal sanctions imposed by intellectual property laws in any jurisdiction, including criminal prosecution.

These Terms of use grant user a limited, non-exclusive, non-transferrable right to use the Site in accordance with these Terms of use.. ERGOMED Group does not confer any license or right under any copyright or trademark or other intellectual property of Ergomed Group or any third party.

No Warranties or Representations
The information contained in this Site is for general information purposes only. The Content of the Site is provided on “as is” basis. While we endeavour to keep the information up to date and correct, ERGOMED Group makes no representation or warranty of any kind, expressed or implied, as to the operation of the Site or its Content, including but not limited to, any implied warranties of merchantability, fitness for any particular purpose, or non-infringement. ERGOMED Group neither warrants nor represents that your use of any Content will not infringe the rights of any third parties nor that Content is accurate, complete or up to date.. Any reliance you place on the Site is therefore strictly at your own risk. In no event, ERGOMED Group assumes liability for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this Site, omissions or errors (including, without limitation, typographical errors and technical errors) in the Content which is subject to change without notice.

This Site contains third-party information and links to other websites over which ERGOMED Group has no control over and does not guarantee for the nature, content and availability of these websites. Wherever practical, in our opinion, such information is marked accordingly. ERGOMED Group is not responsible for the content, reliability and security of the linked websites. ERGOMED Group does not endorse the content, or any products or services of any kind available on such sites.

Every effort is made to keep the Site up and running smoothly. However, ERGOMED Group takes no responsibility for, and will not be liable for, the Site being temporarily unavailable due to technical issues beyond our control.

Forward-Looking Statements
The Site contains forward-looking statements based on beliefs of ERGOMED Group management including, but not limited to, expected development of ERGOMED Group’s business; ERGOMED Group’s growth strategy; sale of shares being offered. When used in the Site, words such as “anticipate”, “believe”, “estimate”, “expect”, “intend”, “plan”, “seek” and “project” are intended to identify forward-looking statements. Such statements reflect the views of ERGOMED Group as of the date made with respect to future events and are subject to certain risks and uncertainties that could cause actual results to be materially different from those projected herein, including, among others, regulatory and legal changes, changes in general economic and business conditions, changes in currency exchange rates and interest rates, introduction of competing products, lack of acceptance of new products or services, our ability to penetrate developing and emerging markets and changes in business strategy. You should not place undue reliance on forward-looking statements which ERGOMED Group management believes are reasonable assumptions as of the date they are made. ERGOMED Group undertakes no obligation to publicly update or revise any forward-looking statements.

This site uses cookies to personalise and customise your experience. No cookies collect personal or sensitive information. By clicking “I Accept", you consent to cookies in accordance with our cookie policy.